Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2002
12/18/2002EP1266027A2 Dynamic sequencing by hybridization
12/18/2002EP1266026A1 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/zeta
12/18/2002EP1266025A1 Protein scaffolds for antibody mimics and other binding proteins
12/18/2002EP1266024A1 High fidelity reverse transcriptases and uses thereof
12/18/2002EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002EP1266013A2 Heparinase iii and uses thereof
12/18/2002EP1266012A2 Proteases
12/18/2002EP1266008A2 Acute neuronal induced calcium binding protein type 1 ligand
12/18/2002EP1266007A1 Human survivin interacting protein 1 (sip-1)
12/18/2002EP1266005A2 Regulation of human lipoxin a4 receptor-like protein
12/18/2002EP1266003A2 Kcnb: a potassium channel protein
12/18/2002EP1266001A2 Human transcription factors
12/18/2002EP1265999A2 Human schizophrenia gene
12/18/2002EP1265998A2 Polypeptides and corresponding polynucleotides for diagnostics and therapeutics
12/18/2002EP1265996A2 Identification of modulators of the interferon gamma signaling pathway and their use in restenosis treatment
12/18/2002EP1265995A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
12/18/2002EP1265993A1 Recombinant adenylcyclase and use thereof for screening molecules with proteolytic activity
12/18/2002EP1265989A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
12/18/2002EP1265926A1 Melanin concentrating hormone receptor chimeric and fusion proteins
12/18/2002EP1265924A2 Il-17 receptor like molecules and uses thereof
12/18/2002EP1265922A2 Agonists and antagonists of the receptor gpr19 and their use in appetite control
12/18/2002EP1265920A2 Angiogenesis-associated proteins, and nucleic acids encoding the same
12/18/2002EP1265919A2 G-protein associated molecules
12/18/2002EP1265918A1 Human immune response proteins
12/18/2002EP1265915A2 Novel compounds
12/18/2002EP1265914A2 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/18/2002EP1265910A2 Nucleic acids, proteins, and antibodies
12/18/2002EP1265624A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof
12/18/2002EP1265582A2 Colon and colon cancer associated polynucleotides and polypeptides
12/18/2002EP1151140A4 A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
12/18/2002EP1135479B1 Formulations and methods for isolating nucleic acids from any complex starting material and subsequent complex genetic analysis
12/18/2002EP0951566B1 A method of purifying dna
12/18/2002EP0946721B1 Human growth gene and short stature gene region
12/18/2002EP0937249B1 Synchronized analyte testing system
12/18/2002EP0934431B1 Method and cellculture for identifying inhibitors of eukaryotic cell processes
12/18/2002EP0925503B1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
12/18/2002EP0925370B1 Biochemical analysis of antioxidant function
12/18/2002EP0892811B1 Peptides with antiproliferative properties
12/18/2002EP0879300B1 Use of primers for universal fingerprint analysis
12/18/2002EP0862655B1 Methods for preparing solid supports for hybridization and reducing non-specific background
12/18/2002EP0859861A4 AMPLIFICATIONS OF CHROMOSOMAL REGION 20q13 AS A PROGNOSTIC INDICATOR IN BREAST CANCER
12/18/2002EP0792376B1 Continuous amplification reaction
12/18/2002EP0778844B1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes
12/18/2002EP0715523B1 Purine nucleoside phosphorylase gene therapy for human malignancy
12/18/2002EP0668930B1 A method of identifying ligands and antagonists of ligands
12/18/2002EP0662150B1 Maspin, a novel serpin with tumor suppressing activity
12/18/2002EP0641385B1 Development of dna probes and immunological reagents of human tumor associated antigens
12/18/2002EP0555370B1 Methods and applications for efficient genetic suppressor elements
12/18/2002EP0135587B2 Defined sequence single strand oligonucleotides incorporating reporter groups, process for the chemical synthesis thereof, and nucleosides useful in such synthesis
12/18/2002CN1386194A 生物传感器 Biosensor
12/18/2002CN1386135A Phytomics: a genomic-based approach to herbal compositions
12/18/2002CN1385702A Method for supply clinical diagnosis
12/18/2002CN1385701A Method and reagent for biological cell identify and count
12/18/2002CN1385690A Biochip analysis instrument
12/18/2002CN1385541A Method for detecting transgenic plant and products thereof
12/18/2002CN1385540A Method for detecting hepatitis c virus PdRP enzyme, carrier and cell strain transformed by same and application
12/18/2002CN1385532A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002CN1385531A Dilutus culex chymotrypsin gene
12/18/2002CN1385529A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002CN1385439A Application of silicon amide shell type nano granular material in nucleic acid enriching and nano sensing process
12/18/2002CN1096627C Compound microarray chip preparing process based on electronic screen plate and silk screen print technology
12/18/2002CN1096501C Reporter enzyme release tech, method of assaying for the presence of aspartic proteases and other hydrolytic enzyme activities
12/18/2002CN1096298C Holder assembly of reaction tubes capable of holding multiple microdrop sample tubes
12/18/2002CA2388761A1 Wound healing biomarkers
12/17/2002US6495742 Stress tolerant plants; genetic engineering
12/17/2002US6495736 Compositions and methods for increasing bone mineralization
12/17/2002US6495676 Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
12/17/2002US6495672 Diagnosis and separation through triplex binding
12/17/2002US6495671 Oligonucleotide and nucleotide amine analogs, methods of synthesis and use
12/17/2002US6495670 Process for typing of HCV isolates
12/17/2002US6495665 Isoforms of mouse serotonin 5-HT2C receptor
12/17/2002US6495553 Methods and compositions for overcoming resistance to biologic and chemotherapy
12/17/2002US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/17/2002US6495370 A method for detecting a glutathione-s-transferase isoenzyme in a biological specimen comprising the measurement of glutathione-s-transferase enzymatic activity in the presence and absence an amount of a compound of the formula halo
12/17/2002US6495367 A blood component deposition-preventing agent and a blood coagulation accelerator are provided, which are substantially indifferent to blood coagulation activity and serum chemistry parameters. also provided is plastic blood test ware and a
12/17/2002US6495361 Method of producing infectious papillomavirus in placental cells
12/17/2002US6495359 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
12/17/2002US6495354 Synthases
12/17/2002US6495350 Amplification of nucleic acid molecules by reverse transcriptase-polymerase chain reaction; moloney murine leukemia virus reverse transcriptase, one or more dna polymerases, and one or more sulfur-containing molecules
12/17/2002US6495348 Mitomycin biosynthetic gene cluster
12/17/2002US6495347 Determining if fusion protein stimulates a th1-like response in cell sample; fusion proteins and conjugates that contain at least a portion of a heat shock protein; response detected by measuring interferon (ifn)-gamma produced by the cell sample
12/17/2002US6495345 Surface antigen
12/17/2002US6495343 Cloning and recombinant production of CRF receptor(s)
12/17/2002US6495338 Drug screening and diagnosis based on paracrine tubular renin-angiotensin system
12/17/2002US6495337 Adding a candidate agent to a mixture comprising myosin under conditions which normally allow production of adp or phosphate; change in level between the presence and absence of agent indicates compound as modulator of myosin
12/17/2002US6495336 Oligopeptide derivatives for the electrochemical measurement of protease activity
12/17/2002US6495328 Substrate for detecting base sequences, method of manufacturing the substrate, and method of detecting base sequences using the substrate
12/17/2002US6495327 Polynucleotide probes for detection and quantitation of Candida albicans and Candida dubliniensis
12/17/2002US6495326 Measuring the decrease in fluorescence from fluorescent dyes labelled to nucleic acids after hybridization with the target nucleic acids to analyze quantitatively; computer-readable recording media; high speed, accuracy and simplification
12/17/2002US6495325 Determining presence or absence of equilibrium in intestinal bacterial flora by comparing a restriction pattern of the amplificate to at least one reference restriction pattern
12/17/2002US6495324 Nanoparticles having oligonucleotides attached thereto and uses therefor
12/17/2002US6495323 Nucleic acids covalently coupled to electrodes via conductive oligomers
12/17/2002US6495321 Randomisation of the entire gene sequence in combination with the selection of a variant (mutant) protein with the desired characteristics, followed by a new round of random mutagenesis and selection
12/17/2002US6495320 Amplification by contacting a single-stranded dna with enzymatic compound 1,10-phenanthroline copper complex attached to a non-specific nucleic acid binding element; synthesis of double-stranded dna; producing copies of sense rna from dsdna
12/17/2002US6495319 Reduced complexity nucleic acid targets and methods of using same
12/17/2002US6495316 Cells suitable for the detection of herpes virus, wherein said cells comprise mrc-5 cells and cv-1 cells
12/17/2002US6495135 Immortalized human keratinocyte cell line
12/17/2002US6495023 Methods using neutral red to mediate the interconversion of chemical and electrical energy. electrically reduced neutral red has been found to promote cell growth and formation of reduced products by reversibly increasing the ratio of the
12/17/2002CA2303591C Method and compositions for preventing or reducing hiv infection
12/17/2002CA2214439C A novel growth factor and a genetic sequence encoding same